West welcomes robert mcmahon as incoming chief financial officer

Exton, pa. , july 21, 2025 /prnewswire/ -- west pharmaceutical services, inc. (nyse: wst), a global leader in innovative solutions for injectable drug administration, today announced the appointment of robert mcmahon as the company's new chief financial officer (cfo), effective august 4, 2025. mr. mcmahon will succeed bernard birkett, cfo, who announced his intention to retire earlier this year.
WST Ratings Summary
WST Quant Ranking